Announcements Trials
Browse Landscape

Phase

Phase 4 3

Status

Completed 2Unknown 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Bile Duct Neoplasms 3Stomach Neoplasms 2Pancreatic Neoplasms 2Esophageal Neoplasms 2Colorectal Neoplasms 2Sigmoid Neoplasms 1Rectal Neoplasms 1Gallbladder Neoplasms 1Erectile Dysfunction 1

Interventions

Gemcitabine 40Cisplatin 24Capecitabine 21Fluorouracil 19Oxaliplatin 17Leucovorin 14pembrolizumab 9Irinotecan 8Radiotherapy 7Erlotinib Hydrochloride 7durvalumab 6Sorafenib 4Photochemotherapy 4Magnetic Resonance Spectroscopy 4Carboplatin 4trametinib 3Trastuzumab 3Radiofrequency Ablation 3Long-Term Synaptic Depression 3Interleukin-12 Subunit p35 3Filgrastim 3Drug Therapy 3Dihematoporphyrin Ether 3Dexamethasone 3Cholangiopancreatography, Endoscopic Retrograde 3Chemotherapy, Adjuvant 3trifluridine tipiracil drug combination 2tivozanib 2tislelizumab 2spartalizumab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Bile Duct Neoplasms × Long-Term Synaptic Depression × Gastrointestinal × Clear all
NCT01256047 2020-02-18

Effects of Preoperative Immunonutrition in Patients Undergoing Hepatectomy

Chiba University

Phase 4 Completed
40 enrolled
Gastrointestinal

Bile Duct Neoplasms

NCT01969110 2013-10-25

Additional Effects of Perioperative Immunonutrition in Patients Undergoing Pancreaticoduodenectomy

Chiba University

Phase 4 Unknown
60 enrolled
Gastrointestinal

Bile Duct Neoplasms, Pancreatic Neoplasms

NCT01256034 2012-10-23

EPIPD

Chiba University

Phase 4 Completed
50 enrolled 6 charts
Gastrointestinal

Bile Duct Neoplasms, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡